ANGIOGENE PHARMACEUTICALS LIMITED
Opportunity 63/100 (worth a look), bankability 70/100. Strong seller-intent signal (78/100, director aged 70). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Resolve: Company dissolved. Company has been dissolved — it no longer legally exists. Any diligence here is historical only. Most likely exit: share sale to pe / searcher (65/100).
Data confidence
Overall: medium (56/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Mixed signal. Worth opening the full target workup before deciding to pursue.
Recent activity
Corporate timeline (37 events)Click to expand
- 2017-01-17📄gazette-dissolved-voluntarygazette · GAZ2(A)
- 2017-01-17🏁Company dissolved
- 2016-11-01📄gazette-notice-voluntarygazette · GAZ1(A)
- 2016-10-26📄dissolution-application-strike-off-companydissolution · DS01
- 2015-12-04📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2015-08-10📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2014-12-04📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2014-10-06📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2014-04-09📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2013-08-07📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2013-08-07📄change-corporate-secretary-company-with-change-dateofficers · CH04
- 2013-04-25📍change-registered-office-address-company-with-date-old-addressaddress · AD01
- 2013-02-12📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2012-08-13📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2012-05-03📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2011-07-28📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2011-04-28📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2010-09-02📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2010-09-02📄change-corporate-secretary-company-with-change-dateofficers · CH04
- 2010-03-02📄accounts-with-accounts-type-smallaccounts · AA
- 2009-08-13📄legacyannual-return · 363a
- 2008-12-10📄accounts-with-accounts-type-smallaccounts · AA
- 2008-07-29📄legacyannual-return · 363a
- 2008-01-09📄accounts-with-accounts-type-smallaccounts · AA
- 2007-08-16📄legacyannual-return · 363a
- 2006-03-12➖CHAPLIN, David John, Dr resigneddirector
- 2002-07-01➕1924 NOMINEES LTD appointedcorporate-secretary
- 2002-07-01➖ARCHIBALD CAMPBELL & HARLEY resignedcorporate-secretary
- 1998-11-13➕DAVIS, Peter David, Dr appointeddirector
- 1997-01-15➕DOUGHERTY, Graeme John, Dr appointeddirector
- 1997-01-15➕ARCHIBALD CAMPBELL & HARLEY appointedcorporate-secretary
- 1997-01-15➖OSWALDS OF EDINBURGH LIMITED resignedcorporate-nominee-secretary
- 1997-01-15➕CHAPLIN, David John, Dr appointeddirector
- 1997-01-15➖JORDANS (SCOTLAND) LIMITED resignedcorporate-nominee-director
- 1996-07-22🏢Company incorporatedAs ANGIOGENE PHARMACEUTICALS LIMITED
- 1996-07-22➕OSWALDS OF EDINBURGH LIMITED appointedcorporate-nominee-secretary
- 1996-07-22➕JORDANS (SCOTLAND) LIMITED appointedcorporate-nominee-director
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Long-tenure founder: Senior director has been in place 29 years — deep operational knowledge concentrated in one person.
- +Founder age: Director aged approximately 70 — succession pressure is live.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 70+: Senior director is approximately 70 years old. Natural succession window is now.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
- primary20+ year tenure: Director in role 29 years. Very long tenure is a classic succession signal.
- secondaryStable-but-static management: Company is 30 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
1 high ·Company has been dissolved — it no longer legally exists. Any diligence here is historical only.
Evidence: Dissolved on 2017-01-17
Shareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Peter David Davis Individual · Uk · DOB 08/1956 · age 70 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Manufacturing · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 1NHALER LTD→ SC573454 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AB ACCESS SOLUTIONS LTD→ SC353334 · est 2009 · no financials extracted | — | — | — | — | 17y | — | — |
| ABBEY PRINT AND DESIGN LIMITED→ SC252359 · est 2003 · no financials extracted | — | — | — | — | 22y | — | — |
| ACHILTIBUIE HIGHLAND REEDS LTD.→ SC256666 · est 2003 · no financials extracted | — | — | — | — | 22y | — | — |
| AD BUD LTD→ SC635643 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AERIES FRAMEWORKS LTD→ SC870587 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AFROSOLACE LTD→ SC875818 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AG 20061 LTD→ SC875445 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AG LOCUM PHARMACY SERVICES LIMITED→ SC871027 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AGATA NATURALS LTD→ SC796544 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AGE REVERSAL EUROPE LTD.→ SC151367 · est 1994 · no financials extracted | — | — | — | — | 31y | — | — |
| AGILICO (SCOTLAND) LIMITED→ SC080982 · est 1982 · no financials extracted | — | — | — | — | 43y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (0 active · 4 resigned)
Click a director name to see their full track record across all companies.